Multiple biomarkers for the prediction of first major cardiovascular events and death.
By Thomas J. Wang, P. Gona, Martin G. Larson, G. Tofler, Daniel Levy, C. Newton‐Cheh, P. Jacques, N. Rifai, J. Selhub, S. Robins and 3 more. New England Journal of Medicine, 2006
1,399 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Immunology
View Paper: https://www.semanticscholar.org/paper/baa494e8782f6c1c6180677a8ed47d25ac479ca5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- P. Ridker
- Michael J. Pencina
- Ramachandran S. Vasan
- N. Rifai
- Ralph B. D’Agostino
- Nancy R. Cook
- E. Lakatta
- S. Laurent
In Epidemiology
- P. Ridker
- N. Rifai
- Michael J. Pencina
- Olga V. Demler
- Nancy R. Cook
- Ralph B. D’Agostino
- Peter Libby
- L. Melvin
In Immunology
Citations in the corpus
- Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. (2008, background): “In a more extreme example, Wang et al. ( 15 ) examined a risk score for cardiovascular disease that was based on multiple plasmabiomarkers.Estimatesof8-yearriskofall-cause mortality in the high risk (top 20% of risk scores) and low risk (bottom 40% of risk scores) groups were 20% and 3%, respectivel”
- Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects (2013, background): “Our goal was to address the questions of whether having information on aPWV for both unselected, population-based individuals and patients with manifest disease improved the prediction of future cardiovascular events; whether risk prediction varied according to subgroups; and whether improved risk H”
- 2007 ESH‐ESC Guidelines for the management of arterial hypertension (2007, background): “(168) Although high sensitivity C reactive protein (hsCRP) has been reported to predict the incidence of cardiovascular events in several clinical settings, (169) its added value in determining total cardiovascular risk is uncertain, (170) except in patients with metabolic syndrome in whom hsCRP val”
- Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. (2007, result): “Our findings might appear to conflict with a recent report from the FraminghamHeartStudy inwhichonlymarginal utility for novel risk factors was described.(16)However,insteadofseekingevidenceof reclassification, thatanalysis relied solely on the C statistic, a technique known to have limited utility ”
- Phenomics: the next challenge (2010, neutral): “Several longitudinal and multi-generational epidemiological studies have already been used to study health-related phenotype”
- Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? (2008, background): “(23) recently demonstrated that the addition of multimarker”
- A comparative study of different machine learning methods for landslide susceptibility assessment: A case study of Uttarakhand area (India) (2016, background): “htm), and r represents retention threshold (Wang et al., 2006).”